Prevention of progression of diabetic nephropathy by the SGLT2 inhibitor ipragliflozin in uninephrectomized type 2 diabetic mice
Author:
Publisher
Elsevier BV
Subject
Pharmacology
Reference29 articles.
1. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes;Patel;N. Engl. J. Med.,2008
2. Comparative renal protective effects of canagliflozin and telmisartan in a rat model of diabetic nephropathy;Abdel-Wahab;J. Nephrol. Ren. Ther.,2016
3. Telmisartan is more effective than losartan in reducing proteinuria in patients with diabetic nephropathy;Bakris;Kidney Int.,2008
4. SGLT-2 inhibitors: a new mechanism for glycemic control;Chao;Clin. Diabet.,2014
5. Residual microvascular risk in diabetes: unmet needs and future directions;Fioretto;Nat. Rev. Endocrinol.,2010
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The importance of proinflammatory failed-repair tubular epithelia as a predictor of diabetic kidney disease progression;iScience;2024-02
2. Protective Effect of Ipragliflozin on Acute Brain Injury Induced by Endotoxemia in Mice;Iranian Journal of War and Public Health;2023-10-01
3. FTZ polysaccharides ameliorate kidney injury in diabetic mice by regulating gut-kidney axis;Phytomedicine;2023-09
4. A systematic review on renal effects of SGLT2 inhibitors in rodent models of diabetic nephropathy;Pharmacology & Therapeutics;2023-09
5. Transcription factor c-Maf deletion improves streptozotocin-induced diabetic nephropathy by directly regulating Sglt2 and Glut2;JCI Insight;2023-03-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3